Atomo Diagnostics Ltd (ASX: AT1) Share Price and News

Price

$0.018

Movement

0.0015 (+9.09%)

as at 23 May - Closed (20 mins delayed)

52 Week Range

$0.016 - $0.031

 
1 Year Return

-41.94%

Atomo Diagnostics Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $12.35 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 686.13 million
Earnings per share -0.010
Dividend per share N/A
Year To Date Return -13.16%
Earnings Yield N/A
Franking -
Share Price

$0.018

Day Change

0.0015 (+9.09%)

52 Week Range

$0.016 - $0.031

Yesterday's Close

$0.0165

Today's Open

$0.018

Days Range

$0.018 - $0.018

Volume

55,002

Avg. Volume (1 month)

340,313

Turnover

$990

as at 23 May - Closed

Atomo Diagnostics Ltd (ASX: AT1)
Latest News

woman sitting at desk holding hand up in stop motion
Healthcare Shares

Why is the Atomo Diagnostics (ASX:AT1) share price halted?

Atomo shares currently sit in a requested trading halt. Read on for more details.

Read more »

Investor with palm up and graphic illustration of asx small cap tech shares charts shooting from his hand
Share Gainers

These were the 5 top performing ASX shares in September

Here are the top 5 for September.

Read more »

child holds swab and testing cup
Share Market News

Why the Atomo Diagnostics (ASX:AT1) share price has rallied 15% today

Shares in the medical devices company are on the rise again. Here are the details

Read more »

Sonic Healthcare share price represented by man receiveing nasal swab from medical professional
Share Gainers

Why the Atomo Diagnostics (ASX:AT1) share price has soared 30% in a week

The medical device company has had a terrific week.

Read more »

A healthcare worker wearing a white coat holds his fingers to his mouth looking worried as healthcare stocks like Cochlear crash today
Earnings Results

Atomo Diagnostics (ASX:AT1) share price sinks 8% on FY21 results

Investors have been selling this medical device company's shares on Friday...

Read more »

Woman prepares to insert a swab in her nose to test for COVID-19 at home.
Share Gainers

Here's why the Atomo (ASX: AT1) share price flew 4% higher today

The rapid COVID-19 test provider has been in the spotlight today.

Read more »

a man sits on a rocket propelled office chair and flies high above a city
Share Market News

The Atomo (ASX:AT1) share price has shot up 9%. Here's why

The diagnostics company released its fourth-quarter business update today.

Read more »

Woman prepares to insert a swab in her nose to test for COVID-19 at home.
Healthcare Shares

Ellume is making news and these ASX shares are surging, again

You can't buy shares in Ellume on the ASX, but here's the next best.

Read more »

Graphic showing yellow arrow above vertical columns indicating a rising share price
Healthcare Shares

Here's why the Atomo (ASX:AT1) share price is soaring 10%

Personal rapid COVID-19 tests are in the news today, and the Atomo share price is benefitting.

Read more »

green arrow representing a rise in the share price
Share Gainers

Why Atomo, Metcash, Temple & Webster, & Woolworths are pushing higher

These ASX shares have started the week strongly...

Read more »

Vanadium Resources share price person riding rocket indicating share price increase
Share Market News

Atomo Diagnostics (ASX:AT1) share price rockets 59% on COVID-19 test update

This ASX share is starting the week with a bang...

Read more »

A fit man flexes his muscles, indicating a positive share price movement on the ASX market
Healthcare Shares

The Atomo (ASX:AT1) share price is soaring today. Here's why

The Atomo (ASX: AT1) share price is up 4.8% today on news the company will be expanding access to its…

Read more »

AT1 ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
23rd May 2025 2025-05-23T11:27:19 Notice of Extraordinary General MeetingYesNo11:27am231.5M
23rd May 2025 2025-05-23T09:30:59 Atomo Appoints Interim ChairYesNo9:30am1179k
20th May 2025 2025-05-20T09:54:40 Share Purchase Plan Offer OpensYesNo9:54am4402k
20th May 2025 2025-05-20T09:47:15 Target Market DeterminationYesNo9:47am5107k
20th May 2025 2025-05-20T09:46:35 Share Purchase Plan ProspectusYesNo9:46am54451k
9th May 2025 2025-05-09T16:27:43 Change in substantial holdingYesNo4:27pm3743k
5th May 2025 2025-05-05T17:00:32 Final Director's Interest Notice x 3YesNo5:00pm692k
5th May 2025 2025-05-05T16:58:17 Initial Director's Interest Notice x 2YesNo4:58pm4260k
5th May 2025 2025-05-05T16:57:07 Section 708A Cleansing StatementYesNo4:57pm1183k
5th May 2025 2025-05-05T16:56:27 Notification of cessation of securities - AT1YesNo4:56pm413k

About Atomo Diagnostics Ltd

Atomo Diagnostics Limited is a medical device company. Its Rapid Diagnostic Test devices are used both by healthcare professionals and by consumers to screen for a range of diseases and medical conditions

AT1 Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
23 May 2025 $0.02 $0.00 0.00% 55,002 $0.02 $0.02 $0.02
22 May 2025 $0.02 $0.00 0.00% 13,138 $0.02 $0.02 $0.02
21 May 2025 $0.02 $0.00 0.00% 340,482 $0.02 $0.02 $0.02
20 May 2025 $0.02 $0.00 0.00% 56,000 $0.02 $0.02 $0.02
19 May 2025 $0.02 $0.00 0.00% 268,415 $0.02 $0.02 $0.02
16 May 2025 $0.02 $0.00 0.00% 124,602 $0.02 $0.02 $0.02
15 May 2025 $0.02 $0.00 0.00% 20,028 $0.02 $0.02 $0.02
14 May 2025 $0.02 $0.00 0.00% 132,288 $0.02 $0.02 $0.02
12 May 2025 $0.02 $0.00 0.00% 677,600 $0.02 $0.02 $0.02
09 May 2025 $0.02 $0.00 0.00% 611,763 $0.02 $0.02 $0.02
08 May 2025 $0.02 $0.00 0.00% 297,383 $0.02 $0.02 $0.02
07 May 2025 $0.02 $0.00 0.00% 34,000 $0.02 $0.02 $0.02
06 May 2025 $0.02 $0.00 0.00% 450,113 $0.02 $0.02 $0.02
05 May 2025 $0.02 $0.00 0.00% 1,266,941 $0.02 $0.02 $0.02
02 May 2025 $0.02 $0.00 0.00% 313,386 $0.02 $0.02 $0.02
01 May 2025 $0.02 $0.00 0.00% 2,554 $0.02 $0.02 $0.02
30 Apr 2025 $0.02 $0.00 0.00% 159,927 $0.02 $0.02 $0.02
29 Apr 2025 $0.02 $0.00 0.00% 1,130,244 $0.02 $0.02 $0.02
28 Apr 2025 $0.02 $0.00 0.00% 363,986 $0.02 $0.02 $0.02

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
14 Apr 2025 John Kelly Expiry 666,666 $14,666
Options expired.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr John Michael Kelly FounderChief Executive OfficerManaging Director Apr 2010
Mr Kelly has focused on developing and commercializing innovative healthcare products that enhance usability and performance, having started with CR Bard in Europe developing Class III implantable cardiology products. Prior to joining Unilife in 2005, Mr Kelly spent five years at ResMed where he led the New Product Implementation Group and managed the development of the Mirage Swift and Activa mask systems.
Dr Cheri Louise Walker Non-Executive Director Nov 2022
Dr Walker is an executive with more than twenty-five years of experience working with life science and diagnostic companies. Dr. Walker is currently the President, Chief Executive Officer, and Director of Rhinostics. She has previously held senior executive positions at Abcam; Charles River Labs; Qiagen, and Life Technologies, now part of ThermoFisher. He is a member of the Risk Committee.
Mr Anthony May Non-Executive Director May 2025
Mr May has held various Director roles across international corporations including Hoechst Germany, Microgenics Corporation USA, Fisher Scientific and Thermo Fisher Scientific. With experience across public and private pathology laboratories, as well as sales and management roles in the IVD supply sector, he has built a record in business leadership and strategic growth.
Mr Patrick Cook Non-Executive Director May 2025
Mr Cook is a Non-Executive Director and Chair with over 20 years of board level experience and over 30 years experience in senior executive positions in medical devices & point-of-care diagnostics sectors within multinational and listed biotechnology companies Mr Cook currently serves as Non-Executive Director & previously Chair, at Workplace Drug Testing Australasia Ltd and as Committee Member & previously Member of the Executive at Animal Ethics Committee QUT. He previously served as Non-Executive Director & Chair at eWaste Connection Ltd, Board Member at Prostate Cancer Foundation of Australia (Qld).
Mr Mathew Leslie Watkins Company Secretary Jun 2024
-
Mathew Leslie Watkins Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
GZ Family Holdings Pty Ltd 79,787,536 12.48%
Dalraida Holdings Pty Limited 65,120,000 10.19%
Global Health Investment Fund 64,811,280 10.14%
Mr Xiaoyi Lin 11,880,000 1.86%
Grand Challenges Canada 11,390,824 1.78%
Liverbird Pty Ltd 10,931,653 1.71%
Australia West Holdings Pty 10,500,000 1.64%
Australia North Holdings Pty 9,580,000 1.50%
ID&E Pty Ltd 9,032,248 1.41%
Mark Andrew Smith 7,790,224 1.22%
Mr Ian Fredrick Johnson 7,506,080 1.17%
John Michael Kelly 7,370,248 1.15%
Leo James Lynch 7,321,121 1.15%
Citicorp Nominees Pty Limited 6,355,684 0.99%
Mr Ankur Choudhary 5,887,126 0.92%
Ruth Karen Devney 5,626,408 0.88%
Sokolov Pty Ltd 4,031,888 0.63%
H & L Management Pty Ltd 4,000,000 0.63%
Rue Des Rocs Pty Ltd 3,800,000 0.59%
Miss Lisa Marie Mackenzie 3,351,968 0.52%

Profile

since

Note